Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 224

Similar articles for PubMed (Select 21062333)

1.

Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.

Bondareva IB, Jelliffe RW, Andreeva OV, Bondareva KI.

J Clin Pharm Ther. 2011 Oct;36(5):625-36. doi: 10.1111/j.1365-2710.2010.01215.x. Epub 2010 Nov 10.

2.

Population pharmacokinetic modelling of carbamazepine in epileptic elderly patients: implications for dosage.

Bondareva IB, Jelliffe RW, Gusev EI, Guekht AB, Melikyan EG, Belousov YB.

J Clin Pharm Ther. 2006 Jun;31(3):211-21.

PMID:
16789986
3.

Nonparametric population modeling of valproate pharmacokinetics in epileptic patients using routine serum monitoring data: implications for dosage.

Bondareva IB, Jelliffe RW, Sokolov AV, Tischenkova IF.

J Clin Pharm Ther. 2004 Apr;29(2):105-20.

PMID:
15068399
4.
5.
7.

Lack of interaction of gabapentin with carbamazepine or valproate.

Radulovic LL, Wilder BJ, Leppik IE, Bockbrader HN, Chang T, Posvar EL, Sedman AJ, Uthman BM, Erdman GR.

Epilepsia. 1994 Jan-Feb;35(1):155-61. Erratum in: Epilepsia 1994 May-Jun;35(3):707.

PMID:
8112239
8.

Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.

Jankovic SM, Milovanovic JR.

Methods Find Exp Clin Pharmacol. 2007 Dec;29(10):673-9. doi: 10.1358/mf.2007.29.10.1116313.

PMID:
18200330
9.

Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College Hospital.

Habib M, Khan SU, Hoque A, Mondal BA, Hasan AT, Chowdhury RN, Haque B, Rahman KM, Chowdhury AH, Ghose SK, Mohammad QD.

BMC Res Notes. 2013 Nov 18;6:473. doi: 10.1186/1756-0500-6-473.

10.

Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.

Zeng K, Wang X, Xi Z, Yan Y.

Clin Neurol Neurosurg. 2010 May;112(4):291-5. doi: 10.1016/j.clineuro.2009.12.014. Epub 2010 Jan 13.

PMID:
20071075
11.

Color vision in epileptic adolescents treated with valproate and carbamazepine.

Verrotti A, Lobefalo L, Priolo T, Rapinese M, Trotta D, Morgese G, Gallenga PE, Chiarelli F.

Seizure. 2004 Sep;13(6):411-7.

PMID:
15276145
12.

Valproate and carbamazepine comedication changes hepatic enzyme activities in sera of epileptic children.

Cepelak I, Zanić Grubisić T, Mandusić A, Rekić B, Lenicek J.

Clin Chim Acta. 1998 Aug 28;276(2):121-7.

PMID:
9764730
13.

Moclobemide monotherapy vs. combined therapy with valproic acid or carbamazepine in depressive patients: a pharmacokinetic interaction study.

Rakic Ignjatovic A, Miljkovic B, Todorovic D, Timotijevic I, Pokrajac M.

Br J Clin Pharmacol. 2009 Feb;67(2):199-208. doi: 10.1111/j.1365-2125.2008.03326.x. Epub 2008 Dec 5.

15.
16.

Drug interaction profile of topiramate.

Bourgeois BF.

Epilepsia. 1996;37 Suppl 2:S14-S17. Review.

PMID:
8641241
17.

Valproate population pharmacokinetics in children.

Serrano BB, García Sánchez MJ, Otero MJ, Buelga DS, Serrano J, Domínguez-Gil A.

J Clin Pharm Ther. 1999 Feb;24(1):73-80.

PMID:
10319910
18.

[The clinical relevance of serial determinations of plasma concentrations of carbamazepine and sodium valproate].

Hernández-Fustes OJ, Marcourakis T, de Bittencourt PR.

Rev Neurol. 1999 Jun 1-15;28(11):1043-7. Spanish.

PMID:
10390769
19.

Measurement of levetiracetam drug levels to assist with seizure control and monitoring of drug interactions with other anti-epileptic medications (AEMs).

Stepanova D, Beran RG.

Seizure. 2014 May;23(5):371-6. doi: 10.1016/j.seizure.2014.02.003. Epub 2014 Feb 17.

PMID:
24630809
20.

Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.

Blanco-Serrano B, Otero MJ, Santos-Buelga D, García-Sánchez MJ, Serrano J, Domínguez-Gil A.

Biopharm Drug Dispos. 1999 Jul;20(5):233-40.

PMID:
10594867
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk